Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/19
End: 10/21/22
Due: 10/21/23
Phase: N/A
Priority: Normal
Start: 08/10/22
End: 08/23/23
Due: 08/23/24
Phase: N/A
Priority: Normal
Start: 03/26/24
End: 08/01/25
Due: 08/01/26
Phase: N/A
Priority: Normal
Start: 03/02/22
End: 02/20/23
Due: 02/20/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat | NCT03982225 | AMIpharm Co., Ltd. | user2@example.com | None | 2019-07-01 | 2022-10-21 | 2023-10-21 | - | - | 2025-07-14 |
| Evaluate Pharmacokinetic/Pharmacodynamic and Safety/Tolerability of AYP-101 in Healthy Subjects | NCT05476094 | AMIpharm Co., Ltd. | user2@example.com | None | 2022-08-10 | 2023-08-23 | 2024-08-23 | - | - | 2025-07-14 |
| Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area | NCT06256445 | AMIpharm Co., Ltd. | user2@example.com | None | 2024-03-26 | 2025-08-01 | 2026-08-01 | - | - | 2025-07-14 |
| Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area | NCT05266729 | AMIpharm Co., Ltd. | user2@example.com | None | 2022-03-02 | 2023-02-20 | 2024-02-20 | - | - | 2025-07-14 |